I actually just learned of the company yesterday. I have only done surface DD outside of what I learned on the call. I did buy a starter position yesterday. I do have a link for the call but it is on the subscription side of Stock Gumshoe and they consider it proprietary info so I don't feel comfortable sharing it. Sorry. What I liked: The science is potentially life altering. They are the only company currently pursuing this angle through the mitochondria. They have a tremendous IP portfolio. Their officers appear to be 1st class. They have gotten to the point of be ready to start human trials with only raising 18 million dollars. That is pretty much unheard of. They did issue an s-1 in September for a little over 6 million shares at about 2.70 a share. So the price may pull back some from yesterday. I am not shilling for the other sight but Dr. KSS is unparalleled in his willingness to share his knowledge and answer questions pertaining to biotech. I have an oversized (for me) investment in ARTH which is how I found out about SG and Dr. Kss. He thinks this may be the most exciting company He has found in years.
News 
Market Data 
Discover 
